Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Stoke Therapeutics Inc buy SVB Leerink LLC

Stoke Therapeutics Inc
Start price
€11.50
14.10.24 / 50%
Target price
€16.50
14.10.25
Performance (%)
159.13%
End price
€29.80
15.10.25
Summary
This prediction ended on 15.10.25 with a price of €29.80. The BUY prediction by SVB_Leerink_LLC for Stoke Therapeutics Inc saw massive gains of 159.13%. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Stoke Therapeutics Inc -3.414% -3.414% 69.750%
iShares Core DAX® -1.059% 5.007% 6.596%
iShares Nasdaq 100 -2.387% 0.864% 25.791%
iShares Nikkei 225® -4.361% 1.211% 41.309%
iShares S&P 500 -1.778% 1.391% 21.037%

Comments by SVB_Leerink_LLC for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 159.13%
Target price 16.495
Change
Ends at 14.10.25

Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $18.00 price target on the stock.
Ratings data for STOK provided by MarketBeat

SVB Leerink LLC 
0
Report Share
14.10.24
In the thread Trading Stoke Therapeutics Inc
Prediction Buy
Perf. (%) 159.13%
Target price 16.495
Change
Ends at 14.10.25

Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten

SVB Leerink LLC 
0
Report Share
15.10.25